C. Ferri et al., OCTREOTIDE, A SOMATOSTATIN ANALOG, REDUCES INSULIN-SECRETION AND INCREASES RENAL NA+ EXCRETION IN LEAN ESSENTIAL HYPERTENSIVE PATIENTS, American journal of hypertension, 6(4), 1993, pp. 276-281
The influence of insulin on renal Na+ excretion is still subject to de
bate. In order to evaluate the effect of insulin suppression on Na+ ex
cretion, 20 never-treated essential hypertensive men and 8 normotensiv
e men were studied. All subjects had a body mass index <27 kg/m2. Both
the glucose and the lipid metabolisms were normal. After 2 weeks unde
r normal NaCl intake (120 mEq NaCl daily), either octreotide, a somato
statin analog, or vehicle were infused in a forearm vein during acute
volume expansion (0.30 mL/kg/min isotonic saline given intravenously o
ver a period of 30 min). A double-blind randomized cross-over design w
as followed, and each subject was given both infusions at a 1 week int
erval. Blood and urine samples were taken at times - 60, 0, 30, 60, 90
, 120, 180, 240, and 300 min. Our data showed that octreotide signific
antly lowered insulin levels in both hypertensives (from 12.2 +/- 2.4
muU/mL at time 0 to undetectable values at time 30 and 60 min) and nor
motensives (from 11.5 +/- 2.8 muU/mL at time 0, to undetectable values
at time 30 and 60 min). Compared to saline infusion alone, octreotide
significantly increased Na+ excretion in both hypertensives and normo
tensives (saline + octreotide v saline alone P < .05 at time 60 and 90
min). In conclusion, octreotide enhanced the natriuretic response to
intravenous Na+ load in both hypertensives and normotensives. The incr
ease in urinary Na+ was accompanied by a significant decrease in plasm
a insulin levels.